{"slideshow_credits": null, "snippet": "Eric T. Schneiderman, New York&#8217;s attorney general, wrote a letter asking the drug company that makes naloxone to explain why the cost has increased so much, so fast.", "abstract": "New York State Atty Gen Eric T Schneiderman demands explanation from Amphistar Pharmaceuticals, manufacturer of heroin antidote naloxone, for steep increase in price of drug; in April, Schneiderman's office began $5 million program to reimburse police departments across state for purchases of critical lifesaving drug, and has since seen price surge, in some cases even doubling.", "section_name": "N.Y. / Region", "print_page": "23", "document_type": "article", "byline": {"person": [{"lastname": "GOODMAN", "rank": 1, "firstname": "J.", "role": "reported", "organization": "", "middlename": "David"}], "original": "By J. DAVID GOODMAN", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/12/02/nyregion/new-york-attorney-general-critical-of-heroin-antidotes-cost.html", "lead_paragraph": "Eric T. Schneiderman, New York&#8217;s attorney general, wrote a letter asking the drug company that makes naloxone to explain why the cost has increased so much, so fast.", "headline": {"main": "New York Attorney General Critical of Heroin Antidote\u2019s Cost", "print_headline": "Attorney General Critical of Heroin Antidote\u2019s Cost"}, "_id": "547d1e7b38f0d822abda1cba", "word_count": "472", "multimedia": [{"height": 126, "url": "images/2014/12/02/nyregion/SUBy-HEROIN/SUBy-HEROIN-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/12/02/nyregion/SUBy-HEROIN/SUBy-HEROIN-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/12/02/nyregion/SUBy-HEROIN/SUBy-HEROIN-articleLarge.jpg", "legacy": {"xlarge": "images/2014/12/02/nyregion/SUBy-HEROIN/SUBy-HEROIN-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/12/02/nyregion/SUBy-HEROIN/SUBy-HEROIN-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/12/02/nyregion/SUBy-HEROIN/SUBy-HEROIN-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-12-02T00:00:00Z", "source": "The New York Times", "news_desk": "Metro", "keywords": [{"value": "Naloxone (Drug)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Heroin", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Schneiderman, Eric T", "name": "persons", "is_major": "Y", "rank": "3"}, {"value": "Amphastar Pharmaceuticals Inc.", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "New York State", "name": "glocations", "is_major": "Y", "rank": "5"}, {"value": "Police", "name": "subject", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}